AATI develops, manufactures and markets high-throughput, fully-automated nucleic acid analysis systems. The company's products have both commercial and research applications and are designed to improve processes within the molecular diagnostics, pharmaceutical, life science, agricultural and biofuels industries. The company's product portfolio includes instruments for the parallel analysis of biomolecules, DNA, RNA, genomic DNA, double-stranded DNA, pharmaceutical compounds and proteins using capillary electrophoresis (CE) with fluorescence detection or UV absorbance.
The company's flagship product, the Fragment Analyzer™, is recognized as the best-in-class, multi-channel, automated fluorescence-based CE detection system for the simultaneous analysis of the quantity and quality of nucleic acids, including: dsDNA fragments, gDNA, NGS fragments and RNA (total and messenger), and microsatellites (SSR).
Our technology platform also powers the OLIGO PRO II™ for oligonucleotide analysis.
The company has facilities in Ankeny, Iowa, USA; Paris, France; London, UK and Heidelberg, Germany. We support customers through a global network of distributors and support centers.